VERSES (VERS.NEO), a next-generation AI company providing foundational technology for the contextual computing era announced today that Dr. Karl Friston, Professor of Neuroscience at University College London, Scientific Director of the Wellcome Trust Centre for Neuroimaging, and one of the world’s leading and most cited scientists in the study of the brain and mind, has joined the company as its Chief Scientist to direct and oversee the Company’s advanced AI research and development.
Friston is a world leading expert in the development and application of Active Influence, a method of design of intelligent systems using design principles from nature. This will be integral in ongoing research and development behind the next generation AI systems being developed by VERSES.
“It is with great enthusiasm and excitement that we welcome Karl Friston to VERSES as our Chief Scientist,” said Gabriel René, Founder, and CEO of VERSES. “Dr. Friston’s breakthrough work in neuroscience and biologically-inspired AI, known as Active Inference, aligns beautifully with our vision and mission to enable a “smarter world” where AI powers the applications of the 21st century. As the originator of this principle, it is only fitting that Karl has a significant role in VERSES AI research and development all the way through their applied uses in product commercialization.”
Dr. Friston was ranked the #1 most influential neuroscientist in the world by Semantic Scholar in 2016. He has had a decorative scientific career becoming a Fellow of the Royal Society in 2006 and The Royal Society of Biology in 2012, receiving the Weldon Memorial Prize and Medal in 2013, elected as a member of EMBO in 2014 and the Academia Europaea in 2015, and was a 2016 recipient of the Charles Branch Award for unparalleled breakthroughs in Brain Research and the Glass Brain Award from the Organization for Human Brain Mapping.
“I am delighted and honored to join VERSES. I have seldom met such a friendly, focused, committed, and right-minded group of colleagues. On a personal note, my appointment as Chief Scientist is exactly the kind of dénouement of my academic career I had hoped for – a dénouement that marks the beginning of a new and exciting journey of discovery and enabling,” said Karl Friston.
VERSES recently announced a partnership with Blue Yonder, a company specializing in digital supply chain and omni-channel commerce fulfillment providing solutions to over 3500 of the world’s largest retailers and warehouse distribution providers across 78 countries. VERSES adaptive intelligence and Spatial Twin management applications are expected to be equipped and utilized with Blue Yonder’s global logistics customers.
The next catalysts for the company will come soon with VERSES expected to publish its research paper to arxiv.org in early December, and plans to host a webinar about applications and implications of Active Inference on the future of Artificial Intelligence.
The stock is currently down 1.33% in early trading at time of writing.
Technically, the stock is undergoing its pullback stage of the recent breakout. A breakout which triggered when the stock closed above $0.72. What was once resistance, now becomes new support, and an uptrend is in play while we remain above this support level.
A retest tends to occur after a breakout which allows those who missed out on the break to enter on the retest. The next resistance above remains the $0.95-$1.00 zone.